Quick Answer
Health Catalyst, Inc. reported Cash and Equivalents of $50.81 million for fiscal year 2025.
Health Catalyst, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $50.81M | -79.6% |
| 2024 | $249.65M | +134.9% |
| 2023 | $106.28M | -8.6% |
| 2022 | $116.31M | -39.8% |
| 2021 | $193.23M | +110.1% |
| 2020 | $91.95M | +409.9% |
| 2019 | $18.03M | -36.6% |
| 2018 | $28.43M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $40.30M | -87.7% | -20.5% |
| June 30, 2025 | $50.71M | -74.9% | -85.2% |
| March 31, 2025 | $341.97M | +69.8% | +37.0% |
| December 31, 2024 | $249.65M | +134.9% | -24.0% |
| September 30, 2024 | $328.33M | +245.7% | +62.6% |
| June 30, 2024 | $201.90M | +74.5% | +0.3% |
| March 31, 2024 | $201.37M | +50.9% | +89.5% |
| December 31, 2023 | $106.28M | -8.6% | +11.9% |
- Health Catalyst, Inc. showed a decrease of -79.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, Health Catalyst, Inc.’s cash and equivalents has grown by 78.7% (from $28.43 million to $50.81 million).
- The most recent figure is from Health Catalyst, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: